logo

For the Inventor, By the Inventor

Basel, Switzerland

Bioversys Ag


USPTO Granted Patents = 23


Forward Citations = 33

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Marc Gitzinger (11 out of 13 patents)

silverMedal Sergio Lociuro (9 out of 10 patents)

bronzeMedal Erin M Duffy (9 out of 23 patents)

4.  Ashoke Bhattacharjee (9 out of 35 patents)

5.  Zoltan F Kanyo (9 out of 19 patents)

6.  Glenn E Dale (8 out of 15 patents)

7.  Marilyne Bourotte (7 out of 7 patents)

8.  Joseph A Ippolito (7 out of 16 patents)

9.  Christian Kemmer (6 out of 9 patents)

10.  Vincent Trebosc (5 out of 6 patents)

11.  Stefano Biondi (3 out of 3 patents)

12.  Esther Porras De Francisco (3 out of 3 patents)

13.  Modesto Jesús Remuiñan-Blanco (3 out of 3 patents)

14.  Benoit Deprez (3 out of 16 patents)

15.  Nicolas Willand (3 out of 8 patents)


23 patents:

1. 12509462 - 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES (2025-12-30),
2. 12403133 - Rifabutin treatment methods, uses, and compositions (2025-09-02),
3. 12370184 - Antibiotic combination therapies (2025-07-29),
4. 12297201 - Substituted pyrrolo[2,3-d]pyrimidines as antimicrobials (2025-05-13),
5. 12257241 - Rifabutin treatment methods, uses, and compositions (2025-03-25),
6. 12234238 - Antimicrobial compounds and methods of making and using the same (2025-02-25),
7. 12152031 - Biodefense agents (2024-11-26),
8. 11999739 - Antimicrobials methods of making and using the same (2024-06-04),
9. 11969423 - Compounds (2024-04-30),
10. 11903934 - Rifabutin treatment methods, uses, and compositions (2024-02-20),
11. 11833139 - Rifabutin treatment methods, uses, and compositions (2023-12-05),
12. 11351158 - Rifabutin treatment methods, uses, and compositions (2022-06-07),
13. 11344537 - Rifabutin treatment methods, uses, and compositions (2022-05-31),
14. 11254689 - Compounds (2022-02-22),
15. 11253499 - Compounds (2022-02-22),
Company Overview
Bioversys AG, based in Basel, Switzerland, specializes in the development of innovative solutions for antibiotic resistance and infectious diseases. The company focuses on harnessing advanced technologies, including drug discovery and development, to address critical healthcare challenges. With a commitment to improving patient outcomes, Bioversys leverages its expertise in microbiology and pharmacology to create novel therapeutic options, positioning itself as a key player in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

23 Patents

#24 in Basel

#555 in Switzerland

#27,649 in the World

Basel, CH
Basel, Switzerland

Bioversys Ag

Forward Citations = 33

36 inventors:

goldMedal Marc Gitzinger (11 out of 13 patents)

silverMedal Sergio Lociuro (9 out of 10 patents)

bronzeMedal Erin M Duffy (9 out of 23 patents)

4.  Ashoke Bhattacharjee (9 out of 35 patents)

5.  Zoltan F Kanyo (9 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioversys Ag. Retrieved from https://idiyas.com/company/bioversys-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…